Medicare''s cancer screening gap - why prevention should come first

Medicare might soon pay for cancer screenings that arrive too late to actually help. The program currently focuses on tests that can only spot cancer after it appears, rather than finding the warning signs before illness develops. Research shows that finding and removing those early warning signs could save more lives than catching cancer after it starts. The system seems to treat all screenings equally, even when some are far less useful than others. Think of it like fire safety. Some alarms only go off during a full-blown fire, while others detect danger before it spreads. Medicare seems ready to pay equally for both, even though only the early-warning alarms make a real difference in saving homes—or in this case, lives. The proposed rules don''t match what science says works best for preventing cancer in seniors.For decades, Medicare has been the safety net for older Americans. When decisions in Washington get this wrong, real people pay the price with worse health outcomes. Covering tests that miss precancerous conditions while ignoring better alternatives wastes money and risks more serious illnesses later. True efficiency comes from stopping problems before they start—not just treating them after the damage is done. The solution is simple: Medicare should only cover tests proven to spot precancerous conditions before they turn into cancer. This way, the program actually helps seniors stay healthy, not just react to diseases after they''ve taken hold. The right rules would protect Medicare''s promise to prevent illness, not just diagnose it after it''s too late.